Despite Doctors’ Concerns, Pharmacists Get More Leeway to Offer Treatment With Testing
In the battle against covid, pharmacies became a key place for consumers to seek vaccines and testing. Some states are expanding pharmacists’ work to include directly prescribing drugs for customers who seek some routine, point-of-care tests, such as those for flu or strep throat. But doctor groups oppose the move.
‘The Danger Is Still There’ ― As Omicron Lurks, Native Americans Are Wary of Boosters
Federal data shows that vaccination rates for American Indians and Alaska Natives were some of the highest in the nation, but tribes say resistance has slowed efforts to boost members.
Covid and Schizophrenia: Why This Deadly Mix Can Deepen Knowledge of the Brain Disease
Recent studies from around the world have found that people with schizophrenia are as much as five times as likely to die from covid-19 as the general population. Scientists think the findings suggest schizophrenia is not just a disease of the brain, but also a disease of the immune system.
Delays for Autism Diagnosis and Treatment Grew Even Longer During the Pandemic
Despite increased public awareness, research advances, and wider insurance coverage for autism therapies, children often wait months — in some cases more than a year — to get an autism diagnosis and begin intervention services. The waits can be longer for Black and Latino children, and families in rural areas are also disadvantaged, without access to providers.
Los retrasos en el diagnóstico y tratamiento del autismo aumentaron durante la pandemia
La pandemia retrasó muchos servicios médicos críticos, entre ellos los del autismo. Estos tratamientos son esenciales para los niños recién diagnosticados.
Journalists Recap Coverage of the Ongoing Pandemic and Lead Risks in Schools’ Drinking Water
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Watch: Omicron Subvariant Is Nothing to Sneeze At, Explains KHN’s Public Health Expert
A KHN public health expert discusses the new covid subvariant, seasonal allergies, and the debate over whether Americans will need a fourth vaccination.
KHN’s ‘What the Health?’: The ACA Turns 12
Although its fate was in doubt more than a few times, the Affordable Care Act turned 12 this week. Year 13 could be pivotal in determining how many Americans receive ACA health insurance, and at what price. Meanwhile, three leading credit bureaus agreed to stop using most medical debt to measure U.S. consumers’ creditworthiness. Anna Edney of Bloomberg News, Rachel Cohrs of Stat, and KHN’s Mary Agnes Carey join KHN’s Julie Rovner to discuss these issues and more.
Health Officials See Bright Future in Poop Surveillance
Sewage surveillance is proving so useful in mapping covid trends that many public health officials say it should become standard practice in tracking infectious diseases. Whether that happens will depend on the nation’s ability to make it viable in communities rich and poor.
Pfizer CEO Pushes Yearly Shots for Covid. Not So Fast, Experts Say.
A corporate CEO’s call for a fourth mRNA shot struck those closely watching the pandemic as self-serving. It creates public pressure for a fourth dose of vaccine before government experts have time to assess the evidence and settle on the best course forward.